Brain Metastases of Malignant Melanoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2022-05-20
Clinical Trial Update: E6201 Plus Dabrafenib for the Treatment of Metastatic Melanoma Central Nervous System Metastases (CNS) [Phase 1]
Phase 1 clinical trial evaluating E6201 in combination with dabrafenib for metastatic melanoma with brain metastases; study terminated with …